INmune Bio (INMB) Q2 2024 Earnings
INMB·Reported August 1, 2024·After market close
Diluted EPS came in at $-0.50, beat the $-0.63 consensus by $0.13.
Diluted EPS
$-0.50beat by $0.13
Consensus: $-0.63
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about INmune Bio's Q2 2024 earnings report.
INmune Bio (INMB) reported Q2 2024 earnings on August 1, 2024 after market close.
INmune Bio reported diluted EPS of $-0.50 for Q2 2024.
EPS beat the consensus estimate of $-0.63 by $0.13.
You can read the 10-Q periodic report (0001213900-24-064076) directly on SEC EDGAR. The filing index links above go to sec.gov.